As a regulatory professional, confidence comes from having the answers you need. But what do you do when the answers just aren't there? 2014 RAPS will give you the know-how to tackle your toughest issues.
10/1/2014 - 11/30/2014
Improve how effectively you network and advocate for yourself with ideas and techniques from this on-demand webcast.
Local or global—RAPS has you covered with offices in Washington, DC, Shanghai and Singapore. There are RAPS chapters in Canada, Israel, Switzerland, Taiwan and throughout the United States, and local networks in Australia, Belgium, Brazil, Germany, India, Mexico, The Netherlands, Poland and Singapore.
Placeholder for Higher Logic Forum Discussions - DO NOT DELETE
The Hatch-Waxman Amendments are 30 years’ old this month and
introduced generics as we know them. Its milestone anniversary, combined
with FDA’s recent release of its Draft Guidance on Best Practices in Developing Proprietary Names for Drugs, drives the authors to ask: When it comes to innovative drug products, what’s in a name?
Welcome to our Asia Regulatory Roundup, a new feature exclusively for RAPS members. Each week our roundup will provide you with the latest, most important regulatory news affecting Asia and the companies operating therein.
Welcome to RegBits, a new way to get an at-a-glance look at important regulatory news stories. Today's top stories include a report that FDA's evaluation of antibiotics is lacking, a sea change in the regulation of weight loss drugs, Eli Lilly's push for regulatory harmonization, the UK's breakthrough product designation gets off the ground, and a drug with a side effect of poetry.
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.